Deepinder Goyal’s brain-wearable startup Temple has acquired Longevous, pulling the cofounders into full-time roles steering ...

Core Biogenesis and Faravelli are testing whether the biotech behind facial skincare can be scaled up to treat the rest of ...

Phase 3 results presented in Munich and Barcelona show gains for two life-threatening conditions that quietly steal years ...

Mission Therapeutics pairs brain-penetrant mitochondria drug with NeuraLight’s eye-tracking biomarkers in a multi-country ...

A new industry analysis maps 30-plus microbiome startups against longevity, and finds a field still torn between wellness and ...

NGL 2026 will bring clinicians, scientists, founders and investors together to turn healthspan ideas into clinical action.

A SIRT6 gene therapy trial in senior beagles hit its primary endpoint, lowering biological age and offering a test bed for human medicine.

APLMS will use Singapore, China and India to test how longevity science can translate into function, prevention and healthier ...

Outer Bio’s Yuna platform keeps living human skin functioning for a month, a longer window for testing what actually slows ...

Sam Altman-backed Retro Biosciences is widening its Alzheimer’s trial after early doses showed no red flags. Most drug trials ...

The direct-to-consumer diagnostics company built its name on longevity biomarker panels. Now it’s betting its future on everything else. Two years ago, Mito Health’s pitch was narrow and specific: ...